Cassava sciences files lawsuit against perpetrators of “short and distort” campaign

Austin, texas, nov. 03, 2022 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company, today announced that it has filed a lawsuit in federal court against certain individuals who executed a “short and distort” campaign against the company. the 150+ page complaint alleges that the defendants' disinformation campaign caused a precipitous decline in cassava sciences' stock price, a multi-billion dollar decline in its market capitalization, and delayed the company's work in developing a treatment for alzheimer's disease.
SAVA Ratings Summary
SAVA Quant Ranking